You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
We can use NEAT for this (i.e. spin up a Google Cloud instance from Jenkins, pass off a YAML file to the instance describing the graph ML task, wait for it to complete and upload artifacts to S3).
This strategy has the advantage of:
helping us get NEAT updated
helping us flesh out the general use case of getting automatic embedding and graph ML working with KGHub and other projects (Monarch, eco-kg, others)
I don't think we include any viral proteins right now, so we'd expect the antivirals to have few/no human targets, especially because we aren't doing any inference based off sequence or structure.
Describe the desired behavior
It would be useful for Drug Central to have inferred drug -> drug target edges, which we could formulate as a graph ML link prediction task.
We maybe could/should do this in an automated way, on each build of KG-IDG.
A possible roadmap:
Additional context
Per convo with Tudor et al on IDG just now
The text was updated successfully, but these errors were encountered: